Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer. NICE technology appraisal guidance 212
National Institute for Health and Care Excellence (NICE)
Record ID 32018013374
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta212
Year Published:
2010
URL for published report:
https://www.nice.org.uk/guidance/ta212
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Colorectal Neoplasms
- Bevacizumab
- Oxaliplatin
- Fluorouracil
- Capecitabine
- Antineoplastic Combined Chemotherapy Protocols
- Leucovorin
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.